ZSAN — Zosano Pharma Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro CapSucker Stock
- $9.49m
- $3.23m
- $0.79m
Annual cashflow statement for Zosano Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | |||||
Depreciation | |||||
Non-Cash Items | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | |||||
Capital Expenditures | |||||
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash |